PharmaLogic and Ratio Therapeutics Expand Manufacturing Collaboration for Targeted Alpha Therapy Candidate NESR Q1 2026 Earnings EPS Surprises by 199 Amid Revenue Uncertainty Stock Declines 38 Moodys Upgrades Reliance Industries to Baa1 Two Notches Above Indias Sovereign Rating